This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Aberrant ARID5B expression and its association with Ikaros dysfunction in acute lymphoblastic leukemia
Oncogenesis Open Access 12 November 2018
-
ARID5B polymorphism confers an increased risk to acquire specific MLL rearrangements in early childhood leukemia
BMC Cancer Open Access 25 February 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lacour B, Guyot-Goubin A, Guissou S, Bellec S, Desandes E, Clavel J . Incidence of childhood cancer in France: National Children Cancer Registries, 2000–2004. Eur J Cancer Prev 2010; 19: 173–181.
Eden T . Aetiology of childhood leukaemia. Cancer Treat Rev 2010; 36: 286–297.
Papaemmanuil E, Hosking FJ, Vijayakrishnan J, Price A, Olver B, Sheridan E et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 2009; 41: 1006–U1073.
Trevino LR, Yang WJ, French D, Hunger SP, Carroll WL, Devidas M et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 2009; 41: 1001–U1067.
Ellinghaus E, Stanulla M, Richter G, Ellinghaus D, Kronnie GT, Cario G et al. Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia 2012; 26: 902–909.
Orsi L, Rudant J, Bonaventure A, Goujon-Bellec S, Corda E, Evans T et al. Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE). Leukemia 2012; e-pub ahead of print 29 June 2012; doi:10.1038/leu.2012.148.
Rudant J, Menegaux F, Leverger G, Baruchel A, Nelken B, Bertrand Y et al. Family history of cancer in children with acute leukemia, Hodgkin’s lymphoma or non-Hodgkin’s lymphoma: the ESCALE study (SFCE). Int J Cancer 2007; 121: 119–126.
Rudant J, Orsi L, Menegaux F, Petit A, Baruchel A, Bertrand Y et al. Childhood acute leukemia, early common infections, and allergy: the ESCALE study. Am J Epidemiol 2010; 172: 1015–1027.
Brosselin P, Rudant J, Orsi L, Leverger G, Baruchel A, Bertrand Y et al. Acute childhood leukaemia and residence next to petrol stations and automotive repair garages: the ESCALE study (SFCE). Occup Environ Med 2009; 66: 598–606.
Rudant J, Menegaux F, Leverger G, Baruchel A, Nelken B, Bertrand Y et al. Household exposure to pesticides and risk of childhood hematopoietic malignancies: the ESCALE study (SFCE). Environ Health Perspect 2007; 115: 1787–1793.
Mullighan CG, Su X, Zhang J, Radtke I, Phillips LAA, Miller CB et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009; 360: 470–480.
Ross J, Linabery A, Blommer C, Langer E, Spector L, Hilden J et al. Genetic variants modify susceptibility to leukemia in infants: A Children’s Oncology Group report. Pediatr Blood Cancer 2012; e-pub ahead of print 15 March 2012; doi:10.1002/pbc.24131.
Acknowledgements
We are grateful to Claire Mulot, who was in charge of the biological collection at the Biological Resource Center of Saints-Pères, INSERM U775; the CEPH and the Centre National de Génotypage, who genotyped the cases; and IntegraGen, who genotyped the controls. We thank Florence Demenais and the UMR-946 unit (Inserm-Université Paris Diderot) and Fondation Jean Dausset-CEPH for their support. We express our gratitude to: Marie-Hélène Da Silva, Christophe Steffen and Florence Menegaux (INSERM U1018, Environmental Epidemiology of Cancer), who contributed to the recruitment of the cases; Aurélie Guyot-Goubin and the staff of the French National Registry of Childhood Blood Malignancies, who contributed to case detection and verification; and Sabine Mélèze and Marie-Anne Noel (Institut CSA), who coordinated the selection of the controls. We also thank all of the Société Française de lutte contre les Cancers de l’Enfant et de l’Adolescent (SFCE) principal investigators: André Baruchel (Hôpital Saint-Louis/Hôpital Robert Debré, Paris), Claire Berger (Centre Hospitalier Universitaire, Saint-Etienne), Christophe Bergeron (Centre Léon Bérard, Lyon), Jean-Louis Bernard (Hôpital La Timone, Marseille), Yves Bertrand (Hôpital Debrousse, Lyon), Pierre Bordigoni (Centre Hospitalier Universitaire, Nancy), Patrick Boutard (Centre Hospitalier Régional Universitaire, Caen), Gérard Couillault (Hôpital d’Enfants, Dijon), Christophe Piguet (Centre Hospitalier Régional Universitaire, Limoges), Anne-Sophie Defachelles (Centre Oscar Lambret, Lille), François Demeocq (Hôpital Hôtel-Dieu, Clermont-Ferrand), Alain Fischer (Hôpital des Enfants Malades, Paris), Virginie Gandemer (Centre Hospitalier Universitaire – Hôpital Sud, Rennes), Dominique Valteau-Couanet (Institut Gustave Roussy, Villejuif), Jean-Pierre Lamagnere (Centre Gatien de Clocheville, Tours), Françoise Lapierre (Centre Hospitalier Universitaire Jean Bernard, Poitiers), Guy Leverger (Hôpital Armand-Trousseau, Paris), Patrick Lutz (Hôpital de Hautepierre, Strasbourg), Geneviève Margueritte (Hôpital Arnaud de Villeneuve, Montpellier), Françoise Mechinaud (Hôpital Mère et Enfants, Nantes), Gérard Michel (Hôpital La Timone, Marseille), Frédéric Millot (Centre Hospitalier Universitaire Jean Bernard, Poitiers), Martine Münzer (American Memorial Hospital, Reims), Brigitte Nelken (Hôpital Jeanne de Flandre, Lille), Hélène Pacquement (Institut Curie, Paris), Brigitte Pautard (Centre Hospitalier Universitaire, Amiens), Yves Perel (Hôpital Pellegrin Tripode, Bordeaux), Alain Pierre-Kahn (Hôpital Enfants Malades, Paris), Emmanuel Plouvier (Centre Hospitalier Régional, Besançon), Xavier Rialland (Centre Hospitalier Universitaire, Angers), Alain Robert (Hôpital des Enfants, Toulouse), Hervé Rubie (Hôpital des Enfants, Toulouse), Nicolas Sirvent (L’Archet, Nice), Christine Soler (Fondation Lenval, Nice), and Jean-Pierre Vannier (Hôpital Charles Nicolle, Rouen). This work was supported by the grants from INSERM, the Fondation de France, the Association pour la Recherche sur le Cancer (ARC), the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS), the Agence Française de Sécurité Sanitaire de l’Environnement et du Travail (AFSSET), the association Cent pour sang la vie, the Institut National du Cancer (INCa), the Agence Nationale de la Recherche (ANR), and Cancéropôle Ile de France.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Rudant, J., Orsi, L., Bonaventure, A. et al. Are ARID5B and IKZF1 polymorphisms also associated with childhood acute myeloblastic leukemia: the ESCALE study (SFCE)?. Leukemia 27, 746–748 (2013). https://doi.org/10.1038/leu.2012.244
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2012.244
This article is cited by
-
Aberrant ARID5B expression and its association with Ikaros dysfunction in acute lymphoblastic leukemia
Oncogenesis (2018)
-
Replication analysis confirms the association of several variants with acute myeloid leukemia in Chinese population
Journal of Cancer Research and Clinical Oncology (2016)
-
ARID5B polymorphism confers an increased risk to acquire specific MLL rearrangements in early childhood leukemia
BMC Cancer (2014)